Y
Yaacov Baruch
Researcher at Technion – Israel Institute of Technology
Publications - 64
Citations - 2170
Yaacov Baruch is an academic researcher from Technion – Israel Institute of Technology. The author has contributed to research in topics: Transplantation & Liver transplantation. The author has an hindex of 20, co-authored 64 publications receiving 2045 citations. Previous affiliations of Yaacov Baruch include Rappaport Faculty of Medicine & Rambam Health Care Campus.
Papers
More filters
Journal ArticleDOI
ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV
Peter Ferenci,David E. Bernstein,Jacob Lalezari,Daniel E. Cohen,Yan Luo,Curtis Cooper,Edward Tam,Rui Tato Marinho,Naoky Tsai,A. Nyberg,Terry Box,Ziad Younes,Pedram Enayati,Sinikka Green,Yaacov Baruch,Bal R. Bhandari,Florin Alexandru Caruntu,Thomas Sepe,Vladimir Chulanov,Ewa Janczewska,Giuliano Rizzardini,J. Gervain,Ramon Planas,Christophe Moreno,Tarek Hassanein,Wangang Xie,M. King,Thomas Podsadecki,K. Rajender Reddy +28 more
TL;DR: Twelve weeks of treatment with ABT-450/r-ombitasvir and dasabuvir without ribavirin was associated with high rates of sustained virologic response among previously untreated patients with HCV genotype 1 infection.
Journal ArticleDOI
The fatty acid-bile acid conjugate Aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease.
Rifaat Safadi,Fred M. Konikoff,Mahmud Mahamid,Shira Zelber-Sagi,Shira Zelber-Sagi,Maya Halpern,Tuvia Gilat,Ran Oren,Alice Hershkovitz,Ziva Rosenthal-Galili,Eli Zuckerman,Saif Abu-Mouch,Alexander Fich,Emanuel Sikuler,Assaf Issachar,Nimmer Assy,Yaacov Baruch,Yoav Lurie,Moshe Graif,Naftali Stern,Mariana Yaron,Annat Blank,Dafna Ben Bashat,Meir Mizrahi +23 more
TL;DR: Three months' administration of the fatty acid-bile acid conjugate Aramchol is safe, tolerable, and significantly reduces liver fat content in patients with NAFLD, indicating that Aram chol might be used for the treatment of fatty liver disease.
Journal ArticleDOI
Prevalence and characteristics of pain induced by percutaneous liver biopsy
TL;DR: It is indicated that liver biopsy is a painful condition in most patients, and Mild anxiolytic treatment plus local anesthetic infiltration seem to produce insufficient analgesia, thus indicating that a more profound analgesic treatment is required for better control of this pain.
Journal ArticleDOI
Hepatitis B virus infection in patients with idiopathic liver disease
T. Jake Liang,Yaacov Baruch,Edna Ben-Porath,Rafael Enat,Lucyna Bassan,Nancy V. Brown,Nurit Rimon,Hubert E. Blum,Jack R. Wands +8 more
TL;DR: It is concluded that infection with hepatitis B virus undetectable by conventional assays and with hepatitis C virus may represent important unrecognized causes of idiopathic chronic liver disease in Israel.
Journal ArticleDOI
Effect of vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats.
Nimer Assy,Gadi Spira,Melia Paizi,Larissa Shenkar,Yehudit Kraizer,Tzafra Cohen,Gera Neufeld,Butayna Dabbah,Rafael Enat,Yaacov Baruch +9 more
TL;DR: Exogenous VEGF administration early after partial hepatectomy stimulates liver regeneration in rats, indicating whether or not V EGF165 is a direct mitogen for hepatocytes remains to be determined.